Table 3.
Demographic Variables | JNC7 Guidelinea | 2017 ACC/AHA Guidelinea | Relative % Change Between 2017 ACC/AHA and JNC7 | ||
---|---|---|---|---|---|
% | N (95% CI) | % | N (95% CI) | ||
Sex | |||||
Men | 31.8 (25.3–39.0) | 469 705 (335 115–604 296) | 51.3 (43.5–59.0) | 757 822 (579 225–936 419 | 61.3 |
Women | 40.1 (33.9–46.6) | 714 950 (578 974–850 925) | 59.8 (53.7–65.6) | 1 066 284 (888 365–1 244 202) | 49.1 |
Age group, y | |||||
20–44 | 26.9 (11.6–50.8) | 37 060 (3688–70 431) | 51.6 (26.1–76.3) | 71 021 (16 547–125 494) | 91.6 |
45–64 | 32.7 (24.7–41.8) | 354 650 (244 564–464 735) | 54.2 (44.5–63.5) | 587 397 (436 089–738 704) | 65.6 |
65–79 | 34.6 (27.8–42.0) | 456 174 (335 524–576 824) | 54.3 (46.7–61.8) | 716 870 (560 527–873 213) | 57.1 |
≥80 | 46.8 (37.4–56.4) | 336 770 (251 432–422 109 | 62.4 (53.4–70.5) | 448 817 (349 863–547 772) | 33.8 |
Race/ethnicity | |||||
Non‐Hispanic white | 34.1 (28.6–40.1) | 763 382 (588 615–938 148) | 54.6 (49.0–60.0) | 1 219 352 (982 414–1 456 290) | 59.7 |
Non‐Hispanic black | 44.3 (36.6–52.2) | 237 953 (163 811–312 093) | 61.8 (53.4–69.4) | 331 963 (238 809–425 117) | 39.5 |
Mexican American | 36.6 (23.7–51.7) | 53 236 (24 680–81 792) | 46.3 (32.3–60.9) | 67 478 (34 873–100 081) | 26.7 |
Others | 38.0 (25.4–52.4) | 130 084 (68 856–191 311) | 60.0 (43.9–74.2) | 205 313 (125 873–284 752) | 57.8 |
Total | 36.3 (31.6–41.4) | 1 184 655 (984 128–1 385 182) | 56 (51.2–60.6) | 1 824 106 (1 558 846–2 089 366) | 53.9 |
ACC/AHA indicates American College of Cardiology/American Heart Association; BP, blood pressure; CI, confidence interval; JNC7, seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; NHANES, National Health and Nutrition Examination Survey.
Represents both hypertension and recommended antihypertensive medication.